• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

    4.530 +0.210 (+4.86%)
    Streaming Delayed Price Updated: 11:24 AM EST, Dec 3, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 7,096,365
    Open 4.370
    Bid (Size) 4.530 (14,200)
    Ask (Size) 4.540 (15,300)
    Prev. Close 4.320
    Today's Range 4.330 - 4.565
    52wk Range 3.790 - 12.36
    Shares Outstanding 168,425,907
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Beyond the Hype: AI’s Quiet Revolution in Niche Sectors Reshapes Industries from Medicine to Agriculture
    Artificial intelligence, often spotlighted for its advancements in mainstream applications like conversational agents and autonomous vehicles, is quietly orchestrating a profound transformation across... 
    Via TokenRing AI
    Topics Artificial Intelligence Economy Emissions
    News headline image
    Recursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis on December 8, 2025
    From Recursion Pharmaceuticals
    Via GlobeNewswire

    Performance

    YTD
    -37.2%
    -37.2%
    1 Month
    -16.7%
    -16.7%
    3 Month
    -2.8%
    -2.8%
    6 Month
    +3.2%
    +3.2%
    1 Year
    -40.2%
    -40.2%

    More News

    Read More
    News headline image
    Earnings Scheduled For November 5, 2025 ↗
    Via Benzinga
    News headline image
    popEVE AI: Harvard-Developed Model Set to Revolutionize Rare Disease Diagnosis and Drug Discovery
    Via TokenRing AI
    Topics Artificial Intelligence
    News headline image
    Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock? ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Is Recursion Pharmaceuticals a Meme Stock? ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033
    Via FinancialNewsMedia
    News headline image
    Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033
    From MarketNewsUpdates.com
    Via GlobeNewswire
    News headline image
    Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock ↗
    Via The Motley Fool
    Topics Animal Testing Artificial Intelligence
    News headline image
    AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures
    Via TokenRing AI
    Topics Artificial Intelligence Climate Change Intellectual Property
    News headline image
    Nvidia's AI Reign: A $5 Trillion Bellwether Shaping Wall Street's Fortunes
    Via MarketMinute
    Topics Artificial Intelligence Economy Law Enforcement
    News headline image
    Recursion Pharmaceuticals (NASDAQ:RXRX) Reports Q3 2025 Results with Revenue Miss and Extended Cash Runway ↗
    Via Chartmill
    News headline image
    Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Recursion Announces CEO Transition Plan to Drive Next Phase of Growth
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    News headline image
    AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential
    Via TokenRing AI
    Topics Artificial Intelligence
    News headline image
    3 Things Investors Need to Know About Recursion Pharmaceuticals ↗
    Via The Motley Fool
    Topics Animal Testing Artificial Intelligence
    News headline image
    Recursion to Participate in Upcoming Investor Conferences
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    News headline image
    The AI Imperative: Why Rapid Upskilling is Non-Negotiable for Pharma’s Future
    Via TokenRing AI
    Topics Artificial Intelligence Economy
    News headline image
    AI Revolutionizes Pharma R&D: A New Era of Accelerated Drug Discovery and Personalized Medicine
    Via TokenRing AI
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock? ↗
    Via The Motley Fool
    Topics Artificial Intelligence Economy
    News headline image
    AI Revolutionizes Drug Discovery and Personalized Medicine: A New Era of Healthcare
    Via TokenRing AI
    Topics Animal Testing Artificial Intelligence
    News headline image
    Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Looking For The Next Beyond Meat? Here Are The Top 10 Most Shorted Stocks ↗
    Via Benzinga
    News headline image
    Short Squeeze Frenzy Fuels October's Market Rebound: A Closer Look at Bearish Bets and Bullish Surges
    Via MarketMinute
    Topics Economy Stocks World Trade

    Frequently Asked Questions

    Is Recursion Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
    Yes, Recursion Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
    What exchange does Recursion Pharmaceuticals, Inc. - Class A Common Stock trade on?
    Recursion Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock?
    The ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock is RXRX on the Nasdaq Stock Market
    What is the current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
    The current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 4.530
    When was Recursion Pharmaceuticals, Inc. - Class A Common Stock last traded?
    The last trade of Recursion Pharmaceuticals, Inc. - Class A Common Stock was at 12/03/25 11:24 AM ET
    What is the market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
    The market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 762.97M
    How many shares of Recursion Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
    Recursion Pharmaceuticals, Inc. - Class A Common Stock has 763M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.